Karl-Erik Andersson to Cyclic Nucleotide Phosphodiesterases, Type 5
This is a "connection" page, showing publications Karl-Erik Andersson has written about Cyclic Nucleotide Phosphodiesterases, Type 5.
Connection Strength
0.142
-
Füllhase C, Hennenberg M, Giese A, Schmidt M, Strittmatter F, Soler R, Gratzke C, Andersson KE, Stief C. Presence of phosphodiesterase type 5 in the spinal cord and its involvement in bladder outflow obstruction related bladder overactivity. J Urol. 2013 Oct; 190(4):1430-5.
Score: 0.099
-
Oelke M, Hedlund P, Albrecht K, Ellinghaus P, Stief CG, Jonas U, Andersson KE, Uckert S. Expression of cAMP and cGMP-phosphodiesterase isoenzymes 3, 4, and 5 in the human clitoris: immunohistochemical and molecular biology study. Urology. 2006 May; 67(5):1111-6.
Score: 0.015
-
Werkström V, Svensson A, Andersson KE, Hedlund P. Phosphodiesterase 5 in the female pig and human urethra: morphological and functional aspects. BJU Int. 2006 Aug; 98(2):414-23.
Score: 0.015
-
Küthe A, Montorsi F, Andersson KE, Stief CG. Phosphodiesterase inhibitors for the treatment of erectile dysfunction. Curr Opin Investig Drugs. 2002 Oct; 3(10):1489-95.
Score: 0.012